Skip to main content

Table 2 Viruses identified by FA RP in patients with viral pneumonia according to empiric antibacterial therapy

From: Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship

  Long course Short course Mixed infection
(n = 67) (n = 28) (n = 79)
Rhinovirus/enterovirus 15 (22.4) 6 (21.4) 19 (24.1)
Influenza 14 (20.9) 4 (14.3) 15 (19.0)
Parainfluenza 12 (17.9) 7 (25) 8 (10.1)
Respiratory syncytial virus 8 (11.9) 3 (10.7) 8 (10.1)
Human metapneumovirus 8 (11.9) 3 (10.7) 6 (7.6)
Coronavirus 6 (9.0) 2 (7.1) 8 (10.1)
Adenovirus 3 (4.5) 1 (3.6) 7 (8.9)
Multiple viruses 1 (1.5) 2 (7.1) 8 (10.1)
  1. Data expressed as number (% of total)
  2. No statistically significant differences were found between groups